These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 2536413

  • 1. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K, Wardlaw AJ, Moqbel R, Kay AB.
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT.
    Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
    Földes-Filep E, Braquet P, Filep J.
    Biochem Biophys Res Commun; 1987 Nov 13; 148(3):1412-7. PubMed ID: 2825685
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.
    Bruijnzeel PL, Warringa RA, Kok PT, Hamelink ML, Kreukniet J.
    Drugs; 1989 Nov 13; 37 Suppl 1():9-18; discussion 69-77. PubMed ID: 2547570
    [Abstract] [Full Text] [Related]

  • 6. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes.
    Bruijnzeel PL, Warringa RA, Kok PT, Hamelink ML, Kreukniet H, Koenderman L.
    J Allergy Clin Immunol; 1993 Jul 13; 92(1 Pt 2):159-64. PubMed ID: 8393021
    [Abstract] [Full Text] [Related]

  • 7. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N, Agrawal DK, Suliaman FA, Townley RG.
    Biochem Biophys Res Commun; 1987 Feb 13; 142(3):638-44. PubMed ID: 3030295
    [Abstract] [Full Text] [Related]

  • 8. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
    e Silva PM, Martins MA, Faria Neto HC, Cordeiro RS, Vargaftig BB.
    J Pharmacol Exp Ther; 1991 Jun 13; 257(3):1039-44. PubMed ID: 2046020
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ, Weg VB, Walsh DT, Williams TJ, Nourshargh S.
    Br J Pharmacol; 1994 Oct 13; 113(2):513-21. PubMed ID: 7834203
    [Abstract] [Full Text] [Related]

  • 10. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
    Carolan EJ, Casale TB.
    Ann Allergy; 1992 Oct 13; 69(4):323-8. PubMed ID: 1329582
    [Abstract] [Full Text] [Related]

  • 11. Comparison of three paf-acether receptor antagonist ginkgolides.
    Korth R, Nunez D, Bidault J, Benveniste J.
    Eur J Pharmacol; 1988 Jul 26; 152(1-2):101-10. PubMed ID: 2850196
    [Abstract] [Full Text] [Related]

  • 12. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H, Nabe M, Hopp RJ, Okada C, Bewtra AK, Townley G.
    Agents Actions; 1992 Sep 26; 37(1-2):39-43. PubMed ID: 1456179
    [Abstract] [Full Text] [Related]

  • 13. The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.
    Tsai JJ, Wang TF, Wang SR.
    Asian Pac J Allergy Immunol; 1994 Jun 26; 12(1):65-71. PubMed ID: 7872994
    [Abstract] [Full Text] [Related]

  • 14. The effect of nedocromil sodium on human eosinophil activation.
    Moqbel R, Cromwell O, Kay AB.
    Drugs; 1989 Jun 26; 37 Suppl 1():19-22; discussion 69-77. PubMed ID: 2547563
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of receptor-mediated platelet activation by nedocromil sodium.
    Roth M, Solèr M, Lefkowitz H, Emmons LR, Anstine D, Hornung M, Perruchoud AP.
    J Allergy Clin Immunol; 1993 Jun 26; 91(6):1217-25. PubMed ID: 8389778
    [Abstract] [Full Text] [Related]

  • 16. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW, Peng HC, Ko WC, Hung WC, Su CH, Lin CH, Huang TF, Yen MH, Sheu JR.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):239-46. PubMed ID: 9932729
    [Abstract] [Full Text] [Related]

  • 17. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H, Imanishi N, Natsume Y, Morooka S.
    Eur J Pharmacol; 1994 Nov 15; 269(3):299-309. PubMed ID: 7895770
    [Abstract] [Full Text] [Related]

  • 18. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
    Martins MA, Etienne A, Soulard C, Domingo MT, Braquet P.
    Braz J Med Biol Res; 1989 Nov 15; 22(9):1151-4. PubMed ID: 2636011
    [Abstract] [Full Text] [Related]

  • 19. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E, Joseph D, Vargaftig BB.
    J Immunol; 1991 Oct 15; 147(8):2595-602. PubMed ID: 1655895
    [Abstract] [Full Text] [Related]

  • 20. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T, Numao T, Akutsu I, Makino S.
    J Lipid Mediat; 1992 Oct 15; 5(2):145-9. PubMed ID: 1525356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.